D. Frasca, C. Dahyot-fizelier, and O. Mimoz, La colistine en réanimation. Réanimation. 1 mai, vol.17, issue.3, pp.251-259, 2008.

R. V. Dudhani, J. D. Turnidge, K. Coulthard, R. W. Milne, C. R. Rayner et al., Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection Models, Antimicrob Agents Chemother. mars, vol.54, issue.3, pp.1117-1141, 2010.

, U.I., poudre et solvant pour solution injectable -Base de données publique des médicaments

N. Grégoire, V. Aranzana-climent, S. Magréault, S. Marchand, and W. Couet, Clinical Pharmacokinetics and Pharmacodynamics of Colistin. Clin Pharmacokinet, vol.56, issue.12, pp.1441-60, 2017.

L. Dortet, R. Bonnin, A. Jousset, L. Gauthier, and T. Naas, Émergence de la résistance à la colistine chez les entérobactéries : une brèche dans le dernier rempart contre la panrésistance !, J Anti-Infect. 1 déc, vol.18, issue.4, pp.139-59, 2016.

D. Plachouras, M. Karvanen, L. E. Friberg, E. Papadomichelakis, A. Antoniadou et al., Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gramnegative bacteria, Antimicrob Agents Chemother. août, vol.53, issue.8, pp.3430-3436, 2009.

T. Velkov, P. E. Thompson, R. L. Nation, and J. Li, Structure-Activity Relationships of Polymyxin Antibiotics, J Med Chem. 11 mars, vol.53, issue.5, pp.1898-916, 2010.

N. Martis, S. Leroy, and V. Blanc, Colistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infections: A narrative review for the clinician, J Infect. 1 juill, vol.69, issue.1, pp.1-12, 2014.

Z. Z. Deris, J. D. Swarbrick, K. D. Roberts, M. Azad, J. Akter et al., Probing the penetration of antimicrobial polymyxin lipopeptides into gram-negative bacteria, Bioconjug Chem. 16 avr, vol.25, issue.4, pp.750-60, 2014.

N. Biologiste-infos, , p.105, 2020.

D. M. Dgs_céline, L'antibiorésistance : pourquoi est-ce si grave ?

S. Ministère-des, L. De, and . Santé, , 2020.

E. Masson, La colistine en réanimation

. Em-consulte,

D. Sur,

Y. Liu, Y. Wang, T. R. Walsh, L. Yi, R. Zhang et al., Emergence of plasmidmediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study, Lancet Infect Dis. 1 févr, vol.16, issue.2, pp.161-169, 2016.

S. M. Garonzik, J. Li, V. Thamlikitkul, D. L. Paterson, S. Shoham et al., Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients, Antimicrob Agents Chemother. juill, vol.55, issue.7, pp.3284-94, 2011.

E. Asín-prieto, A. Rodríguez-gascón, and A. Isla, Applications of the pharmacokinetic/pharmacodynamic (PK/PD) analysis of antimicrobial agents, J Infect Chemother Off J Jpn Soc Chemother. mai, vol.21, issue.5, pp.319-348, 2015.

W. Couet, N. Grégoire, P. Gobin, P. J. Saulnier, D. Frasca et al., Pharmacokinetics of colistin and colistimethate sodium after a single 80-mg intravenous dose of CMS in young healthy volunteers, Clin Pharmacol Ther. juin, vol.89, issue.6, pp.875-884, 2011.
URL : https://hal.archives-ouvertes.fr/hal-02472938

S. Magréault, J. Mankikian, S. Marchand, P. Diot, W. Couet et al., Pharmacokinetics of colistin after nebulization or intravenous administration of colistin methanesulphonate (Colimycin®) to cystic fibrosis patients, J Cyst Fibros. 1 mai, vol.19, issue.3, pp.421-427, 2020.

J. Li, R. L. Nation, J. D. Turnidge, R. W. Milne, K. Coulthard et al., Colistin: the reemerging antibiotic for multidrug-resistant Gram-negative bacterial infections, Lancet Infect Dis. sept, vol.6, issue.9, pp.589-601, 2006.

S. Cheah, J. Wang, V. Nguyen, J. D. Turnidge, J. Li et al., New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection, J Antimicrob Chemother. 1 déc, vol.70, issue.12, pp.3291-3298, 2015.

R. V. Dudhani, J. D. Turnidge, R. L. Nation, and J. Li, fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models, J Antimicrob Chemother. sept, vol.65, issue.9, pp.1984-90, 2010.

R. L. Nation, S. M. Garonzik, J. Li, V. Thamlikitkul, E. J. Giamarellos-bourboulis et al., Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?, Clin Infect Dis Off Publ Infect Dis Soc Am. 1 mars, vol.62, issue.5, pp.552-560, 2016.

A. Forrest, S. M. Garonzik, V. Thamlikitkul, E. J. Giamarellos-bourboulis, D. L. Paterson et al., Pharmacokinetic/Toxicodynamic Analysis of Colistin-Associated Acute Kidney Injury in Critically Ill Patients, Antimicrob Agents Chemother, vol.24, 2017.

N. M. Doshi, K. L. Mount, and C. V. Murphy, Nephrotoxicity Associated with Intravenous Colistin in Critically Ill Patients, Pharmacother J Hum Pharmacol Drug Ther, vol.31, issue.12, pp.1257-64, 2011.

L. Dalfino, F. Puntillo, A. Mosca, R. Monno, M. L. Spada et al., High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study, Clin Infect Dis Off Publ Infect Dis Soc Am. 15 juin, vol.54, issue.12, pp.1720-1726, 2012.

R. L. Nation, S. M. Garonzik, V. Thamlikitkul, E. J. Giamarellos-bourboulis, A. Forrest et al., Dosing guidance for intravenous colistin in critically-ill patients, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.01, issue.5, pp.565-71, 2017.

, Résumé des caractéristiques du produit -COLIMYCINE 1.000.000 U.I., poudre et solvant pour solution injectable -Base de données publique des médicaments

R. Disponible-sur-;-garraffo and T. Lavrut, Signification clinique des corrélations pharmacocinétique/pharmacodynamie des antibiotiques chez les patients de réanimation, Réanimation. juin, vol.14, issue.4, pp.264-75, 2005.

V. Jullien, Suivi thérapeutique pharmacologique des antifongiques : de l'intérêt des dosages, Mise Au Point, p.5

S. Baron, Mécanismes de la résistance à la colistine chez les bactéries à gram négatif, vol.124, 2017.

. Ct-16386_colimycine_pis_ri_avis2_ct16386, , 2020.

D. Sur,

S. Figueiredo, P. Leblanc, . Bactéries, and . Résistantes, QUELLES CONSÉQUENCES POUR L'ANESTHÉSISTE-RÉANIMATEUR, p.10

H. Mal and G. Thabut, Prise en charge de la transplantation pulmonaire en réanimation, Réanimation. févr, vol.17, issue.1, pp.50-56, 2008.